Beck Bode LLC’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$26.8M Buy
112,677
+3,656
+3% +$760K 4.05% 3
2026
Q1
$23M Sell
109,021
-6,112
-5% -$1.32M 3.9% 3
2025
Q4
$23.7M Sell
115,133
-10,056
-8% -$1.89M 3.94% 2
2025
Q3
$19.6M Buy
125,189
+974
+0.8% +$150K 3.17% 12
2025
Q2
$20.9M Sell
124,215
-1,061
-0.8% -$157K 3.53% 5
2025
Q1
$17.3M Buy
+125,276
New +$16M 3.22% 9
2020
Q4
Sell
-2,323
Closed -$109K 45
2020
Q3
$109K Buy
+2,323
New +$119K 0.04% 75

Other funds holding CAH

Beck Bode LLC's CAH Position: Q2 2026 in Review

Beck Bode LLC increased its Cardinal Health (CAH) stake by 3.4% in Q2 2026, buying an estimated $760K and bringing the position to 112,677 shares worth $26.8M. The position accounts for 4.05% of the portfolio, ranked #3.

Beck Bode LLC first reported a position in CAH in Q3 2020 and has held it in 7 quarters since. 1,490 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Beck Bode LLC held 112,677 shares of Cardinal Health worth $26.8M as of Q2 2026.
  • Beck Bode LLC bought 3,656 Cardinal Health shares in Q2 2026, an estimated $760K.
  • Cardinal Health made up 4.05% of Beck Bode LLC's portfolio in Q2 2026, its #3 holding.
  • Beck Bode LLC first reported a position in Cardinal Health in Q3 2020 and has held it in 7 quarters since.
  • 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Beck Bode LLC's 13F filing for Q2 2026, filed 13 Aug 2026.